Proteostasis: One drug, many diseases

Emerging Company Profile

Parts of the proteostasis network, such as chaperones, folding enzymes, and the proteasome and degradation processes, are well known and have been targeted by many companies seeking to treat diseases of protein misfolding and aggregation. Proteostasis Therapeutics Inc. is taking a different tack, developing small molecules that recalibrate the network itself...